Pyc Therapeutics Ltd has released a press release.
Appendix 4C - quarterly
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- Quarterly Shareholder Update
- Drug Delivery Greater Than 100% More Effective In Animals
- Conclusion of Genentech Antimicrobial Collaboration
- Retail Offer Document
- PYCs Institutional Entitlement Offer Closes
Later from PYC Therapeutics
- Expansion Of Drug Development Pipeline
- CEO Appointment and Establishment of US Office
- Investor Presentation - February 2020
- Successful Efficacy Result on Path to First in Human Studies
- March 2020 Quarterly Activities and Cash Flow Report
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics